|

Optic Nerve Ultrasound for Assessing Cerebral Inflammation and Intracranial Hypertension in Cerebral Pathologies

RECRUITINGSponsored by Spitalul Clinic de Boli Infecțioase și tropicale "Dr. Victor Babeș"
Actively Recruiting
SponsorSpitalul Clinic de Boli Infecțioase și tropicale "Dr. Victor Babeș"
Started2025-12-01
Est. completion2027-12-01
Eligibility
Age18 Years – 60 Years
Healthy vol.Accepted

Summary

Timely detection of signs of raised intracranial pressure or persistent inflammation within the meninges can expedite therapeutic decisions improving the prognosis of patients with brain damage. Optic nerve ultrasonography provides a user-friendly, safe, low-cost, and non-invasive imaging method that can be easily deployed for ICU patient assessment. This study aims to evaluate the sensitivity and specificity of optic nerve ultrasound in estimating cerebral inflammation extension and cerebral edema in patients in the ICU. The working hypothesis is that optic nerve ultrasound is a useful tool in the rapid diagnosis of cerebral edema and the presence or persistence of cerebral inflammation, which can enable adapted and rapid therapeutic interventions.

Eligibility

Age: 18 Years – 60 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients admitted into one of the specified wards of the involved hospitals
* Patients aged 18-60 years
* Suspected meningitis, encephalitis, stroke or cerebral tumors

Exclusion Criteria:

* Age under 18 years or over 60 years old
* Ocular lesions preventing ocular ultrasound (palpebral infections, cornean erosions, glaucoma, trauma)
* Conditions preventing lumbar puncture (coagulation disorders, epidural abscesses, local infections)

Conditions7

CancerCerebral TumorsIntracranial HypertensionMeningitisMeningitis/EncephalitisStrokeUltrasound

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.